Coronary interventions in Europe 1992 by RÖTHLISBERGER, C. & MEIER, B.
European Heart Journal (1995) 16, 922-929
Coronary interventions in Europe 1992
C . RDTHLISBERGER AND B. MEIER ON BEHALF OF THE WORKING GROUP ON CORONARY CIRCULATION OF THE
EUROPEAN SOCIETY OF CARDIOLOGY
Cardiology, University Hospital, Bern, Switzerland
KEY WORDS: Coronary angiograms, PTCAs, stents in Europe 1992.
The general practice of coronary interventions is influenced by various aspects, traditional, cultural, socioeconomic and
personal. The aim of this survey was to collect the data on coronary interventions in all member countries of the
European Society of Cardiology. The data from 12 of the 35 national members were missing or grossly incomplete and
were therefore excluded from the analysis.
Coronary angiography The total number of coronary angiograms was reported as 683 888, an incidence of
1009 ± 1021 per million inhabitants (range 9 (Romania) to 3076 (Germany)). Germany (246 115 cases), France
(144 754), the United Kingdom (76 296), Italy (45 517) and Spain (43 495) registered 81% of all the coronary
angiograms performed.
Percutaneous transluminal coronary angioplasty (PTCA) The total number of reported PTCAs was 147 729,
which on average accounted for 19 ± 77% (range 2 (Lithuania) to 53% (Netherlands)) of the coronary angiograms.
Most of the PTCAs (82%) were confined to a single vessel. The highest incidence of multivessel PTCA was reported
from Slovakia (28%). PTCA took place immediately after the diagnostic study in only 18% of cases. Adjusted per
capita, Germany ranked first with 703 PTCAs per million inhabitants, followed by Iceland (619), France (614),
Belgium (568) and Austria (485). A major in-hospital complication was reported in 2-5% of the patients undergoing
PTCA: 0-4% hospital deaths, 1-0'% emergency CABGs and 11% myocardial infarctions.
New devices Stents were implanted in 3211 patients (2-7% of all PTCA patients), equally distributed between
emergency situations (53%) and elective procedures. Other interventional devices were applied in 4133 cases (2-8% of
all PTCA cases): directional atherectomy, rotablator, transluminal extraction catheter, laser and Rotacs accounted for
1452, 1232, 55, 558 and 222, respectively. Coronary ultrasound (1350 cases) and coronary angioscopy (373 cases)
were rarely performed.
Coronary artery bypass grafting (CABG) A total of 63 477 patients underwent CABG in the reporting centres
resulting in a PTCAICABG ratio of 2-3. A significant under-reporting of surgery in the participating centres must be
assumed.
Conclusions Although partial reporting might bias conclusions, several findings of this survey are noteworthy: (I)
PTCA was a well accepted treatment for coronary artery disease, (2) PTCA was applied more frequently than CABG,
(3) there was an extremely wide range of coronary angiography and PTCA performed per million inhabitants, (4) the
most common additional procedure was stent implantation, but other new devices were only rarely applied.
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Table I Countries with no or grossly incomplete reporting of data
Algeria
Croatia
Cyprus
Denmark
Egypt
Hungary
Ireland
Morocco
Norway
Portugal
Russia
Tunisia
this survey was to analyse and compare the data on
coronary interventions in the participating countries and
to form a solid information base for future years.
Methods
In March 1993 a detailed questionnaire was sent to all
the presidents of the national cardiac societies belonging
to the European Society of Cardiology. They were asked
to send a copy to all the centres performing coronary
angiograms and coronary interventions in their country,
to collect all the data from those centres, to pool the
figures and to list them on a summary questionnaire.
Attached to the questionnaire were instructions and
examples showing how to complete the form.
The following definitions were used:
Coronary angiograms: Diagnostic catheterizations with
coronary angiography, irrespective of whether per-
formed in conjunction with other diagnostic studies
or PTCA.
PTCA: Coronary angioplasty procedures (cases), irres-
pective of what instrument was used, how many lesions
or vessels were dilated, whether a diagnostic study was
carried out during the same session and whether the
patient had additional procedures during the same year.
PTCA ad hoc: PTCA performed in one session with
the diagnostic study producing the indication for PTCA.
Myocardial infarction: Elevation of creatine kinase to
at least double the upper normal limit.
Single vessel PTCA: PTCA of one or more lesions in
one vessel.
Multivessel PTCA: PTCA of more than one vessel in
the same session.
PTCA for acute infarction: Rescue PTCA with or with-
out fibrinolysis (direct PTCA).
The initial deadline for reporting back was May 1993.
Where data had not been produced by this date a
reminder was issued to the presidents or the persons
assigned by them. If reporting back was still unforth-
coming or incomplete after another 3 months additional
reminders were sent out bimonthly, or the responsible
persons were contacted directly. In April 1994 the
registry was closed.
Results
Reports from 12 of the 35 nations are missing or
grossly incomplete. These 12 (Table 1) were therefore
excluded from the analysis. The data of the 23 remaining
countries, with a total population of 507-7 millions,
form the body of this paper. All important countries in
terms of interventional activity are included.
GENERAL RESULTS
The total number of coronary angiograms and
PTCAs were reported to be 683 888 and 147 729, respec-
tively. The vast majority of PTCAs were performed
electively (89%) and were confined to a single vessel
(82%). PTCA for acute infarction was attempted in 2899
cases. Major complications were reported in 2-5%:
hospital deaths accounted for 0-4%, emergency coronary
artery bypass grafting (CABG) for 1 0% and myocardial
infarction for 11%. New devices including stents (3211
cases), directional atherectomy (1452), rotablator
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Figure I Coronary angiograms per country.
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Figure 2 PTCAs per country.
3500
3000
2500
2000
1500
1000
500
0
1 
1 
1 
1 
1
-
13
07
6
|30
31
CN |24
11
| 2
15
4
| 2
11
0
[I]
 
13
25
J 
11
15
§ o s s Mean
Dn ^ " * Tf TO
II a § B 'a « 1 « ^ ii | c g 3 '§ "S
Dp (_ W » — « > 3 Q . ^ © ^ 3 ^
I
CO
Figure 3 Coronary angiograms per million inhabitants and country.
(1232), laser (558), Rotacs (222), transluminal extraction
catheter (TEC, 55), as well as coronary ultrasound
(1350) and coronary angioscopy (373) were involved in
5-7% of all PTCAs. During the same period 63 477
coronary artery bypass grafting (CABG) procedures
were reported.
DATA ANALYSED PER NATION
The five countries Germany, France, United
Kingdom, Italy, and Spain performed 81% of all cor-
onary angiograms and 80% of all PTCAs (Figs 1 and 2).
The European mean was 1009 ± 1021 coronary angio-
grams per million inhabitants. The highest incidence
of coronary angiograms per million inhabitants was
reported from Germany followed by Iceland and France
(Fig. 3). These three nations also reported the highest
rate of PTCA per million inhabitants (Fig. 4), followed
by Belgium, Austria, Switzerland, and the Netherlands.
The European mean of PTCAs per million inhabitants
was 233 ± 236. The ratio of PTCAs per coronary angio-
grams was highest in The Netherlands (53%) and
Sweden (43%) while the European mean was 19 ± 11%
(Fig. 5). Compared to the countries in western Europe,
coronary angiograms and PTCAs were performed less
frequently in eastern Europe. The percentage of multi-
vessel PTCA is shown in Fig. 6. It ranged from 28% in
Slovakia to 0% in Lithuania and averaged 12 ± 8%
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Figure 4 PTCAs per million inhabitants and country.
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Figure 5 PTCAs per coronary angiograms and country.
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when including also the countries not shown in Fig. 6.
Ad hoc PTCAs were reported in 43% from Switzerland
followed by Austria (39%), Estonia (27%) and Belgium
(23%) (Fig. 7).
NEW THERAPEUTIC DEVICES
The stent was the most frequently used new thera-
peutic device, accounting for 2-7% of all PTCAs. The
indications were fairly equally distributed between
elective (47%) and emergency (53%) situations. Italy,
Germany, France, Spain, and the United Kingdom
implanted 77% of all stents (Fig. 8). There were no
reports of stent implantations in Eastern Europe except
from Poland (2 stents) and Bulgaria (1 stent). Coronary
stenting per PTCA (Fig. 9) averaged 2-8 ± 20% in the
stent implanting countries, the highest incidences being
in Italy (7-9%), Spain (5-7%), and Switzerland (3-6%).
The other new coronary devices are summarized in
Fig. 10. They were applied in only 14 countries and the
majority of the procedures were carried out in Germany
or France. Poland again was the only Eastern European
country using several of these sophisticated and
expensive techniques.
NEW DIAGNOSTIC DEVICES
New diagnostic devices played a minor role and
were applied in only 1-2% of all PTCAs. Germany
and France together accounted for 58% of these
926 C. Rothlisberger et al.
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Figure 6 Multivessel PTCAs per total PTCAs and country.
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Figure 7 Ad hoc PTCAs per total PTCAs and country.
applications. Coronary ultrasound with 1350 applica-
tions was by far the preferred new diagnostic tool in
interventional cardiology, compared to 373 cases of
coronary angioscopy. Except for Sweden, all countries
applying both techniques performed more coronary
ultrasound examinations than coronary angioscopies
(Figs 11 and 12).
Discussion
The incompleteness of the reporting is a drawback of
this survey. Several countries, for instance, Austria,
Switzerland, and The Netherlands have a long tradition
of performing similar surveys of cardiac interventions,
and can rely on an excellent reporting system resulting
in accurate data. The quality of reporting in other
countries is hard to assess. In general, this seemed to be
better from the smaller countries. Adverse events, such
as complications of PTCA, are presumed to be under-
reported. Only a regularly updated data bank run by
professionals not directly involved in the procedures at
each institution could overcome this problem. As the
number of CABGs was collected by the referring cardi-
ologists, under-reporting could be high. All these
methodological limitations must be kept in mind when
analysing the data of this survey. Quality control is
clearly beyond its scope and potential.
In general the number of coronary angiograms,
PTCAs, and newer interventional techniques was at its
height in the west and markedly declined the further east
the European country. However, even among the
wealthy western European countries, the figures for
coronary angiograms and PTCAs per capita vary con-
siderably. The ranking is at least partially affected by the
Coronary interventions in Europe 927
700
600
500
400
300
200
100
0
1
 
1
 
1 
1
 
1
 
1
 
1
647
531
374
316
21J
161
01
o
cd
c
CO
T3
C •I xs«to,-3 OB U
m
o
CO
Figure 8 Stent implantations per country.
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Figure 9 Coronary stent implantations per total PTCAs per country.
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Figure 10 Other new therapeutic devices (except stents) per country. B=Rotacs; BI=Iaser;
G=TEC (transluminal extraction catheter); D=rotablator; •=directional atherectomy.
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Figure 11 Coronary ultrasound per country.
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accuracy of reporting. For example Iceland, with only
one active interventional cardiologist, and other smaller
countries with a long-standing tradition regarding
feedback have almost no missing data and therefore
rank among the most active when corrected per capita.
Relating PTCAs to the number of coronary angiograms
performed per country is very revealing. While most
countries perform a PTCA in 15 to 28% of their
coronary angiograms, the figures for The Netherlands
and Sweden are 53 and 43%, respectively. Two interpre-
tations are possible: either there is under-reporting of
diagnostic studies in these two countries (probably from
non-interventional laboratories) or PTCAs are applied
in a very broad spectrum of indications. It is surprising
that Slovakia ranks first in the percentage of multivessel
PTCAs, although only a total of 64 PTCAs were carried
out. This may suggest a misinterpretation of the
definition of multivessel PTCA in that country.
Among the new therapeutic devices, the coronary
stent seemed to be the most promising tool for the
interventional cardiologist. The percentage of stents per
PTCA varied largely even among the five principal
stenting nations: while stents were implanted in 7-9%
in Italy, Germany reported only a 20% incidence,
although the total amount of stents implanted is
comparable. Other new therapeutic devices played a
minor role in daily interventional practice and were
mostly applied in some wealthy western countries.
In conclusion, PTCA has become a well accepted
treatment for coronary artery disease in Europe and
is reported more frequently than CABG in this survey.
An extremely wide range of coronary angiograms and
PTCAs were performed per million inhabitants, with a
definite decline from West to East in Europe. The most
common additional device in interventional cardiology is
the stent, other newer devices being applied only rarely.
The results of such a survey are highly dependent on
the completeness and accuracy of each questionnaire. It
must be emphasized, therefore, that the better and more
complete the reporting the more valuable is the message
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of such a survey. This implies no loss of data, unbiased
data collection at each centre and prompt and complete
reporting to the collecting agency. In future it is hoped
that every centre in Europe will comply to produce even
more valuable yearly reports.
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